149 related articles for article (PubMed ID: 17374709)
1. The calcium-sensing receptor is a target of autoantibodies in patients with autoimmune polyendocrine syndrome type 1.
Gavalas NG; Kemp EH; Krohn KJ; Brown EM; Watson PF; Weetman AP
J Clin Endocrinol Metab; 2007 Jun; 92(6):2107-14. PubMed ID: 17374709
[TBL] [Abstract][Full Text] [Related]
2. Activating autoantibodies against the calcium-sensing receptor detected in two patients with autoimmune polyendocrine syndrome type 1.
Kemp EH; Gavalas NG; Krohn KJ; Brown EM; Watson PF; Weetman AP
J Clin Endocrinol Metab; 2009 Dec; 94(12):4749-56. PubMed ID: 19837919
[TBL] [Abstract][Full Text] [Related]
3. Mapping of human autoantibody binding sites on the calcium-sensing receptor.
Kemp EH; Gavalas NG; Akhtar S; Krohn KJ; Pallais JC; Brown EM; Watson PF; Weetman AP
J Bone Miner Res; 2010 Jan; 25(1):132-40. PubMed ID: 19580466
[TBL] [Abstract][Full Text] [Related]
4. Calcium-Sensing Receptor Autoantibodies in Patients with Autoimmune Polyendocrine Syndrome Type 1: Epitopes, Specificity, Functional Affinity, IgG Subclass, and Effects on Receptor Activity.
Habibullah M; Porter JA; Kluger N; Ranki A; Krohn KJE; Brandi ML; Brown EM; Weetman AP; Kemp EH
J Immunol; 2018 Dec; 201(11):3175-3183. PubMed ID: 30381479
[TBL] [Abstract][Full Text] [Related]
5. Autoantibodies against the calcium-sensing receptor and cytokines in autoimmune polyglandular syndromes types 2, 3 and 4.
Kemp EH; Kahaly GJ; Porter JA; Frommer L; Weetman AP
Clin Endocrinol (Oxf); 2018 Jan; 88(1):139-145. PubMed ID: 28941288
[TBL] [Abstract][Full Text] [Related]
6. Calcium-sensing receptor autoantibodies and idiopathic hypoparathyroidism.
Tomar N; Gupta N; Goswami R
J Clin Endocrinol Metab; 2013 Sep; 98(9):3884-91. PubMed ID: 23873991
[TBL] [Abstract][Full Text] [Related]
7. Identification of tryptophan hydroxylase as an intestinal autoantigen.
Ekwall O; Hedstrand H; Grimelius L; Haavik J; Perheentupa J; Gustafsson J; Husebye E; Kämpe O; Rorsman F
Lancet; 1998 Jul; 352(9124):279-83. PubMed ID: 9690408
[TBL] [Abstract][Full Text] [Related]
8. Novel neuronal and endocrine autoantibody targets in Autoimmune Polyendocrine Syndrome type 1.
Cocco C; Meloni A; Mariotti S; Cossu E; D'amato F; Zulian S; Tongiorgi E; Ferri GL
Autoimmunity; 2012 Sep; 45(6):485-94. PubMed ID: 22506635
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and clinical associations of calcium-sensing receptor and NALP5 autoantibodies in Finnish APECED patients.
Kemp EH; Habibullah M; Kluger N; Ranki A; Sandhu HK; Krohn KJ; Weetman AP
J Clin Endocrinol Metab; 2014 Mar; 99(3):1064-71. PubMed ID: 24423312
[TBL] [Abstract][Full Text] [Related]
10. Testis-expressed protein TSGA10 an auto-antigen in autoimmune polyendocrine syndrome type I.
Reimand K; Perheentupa J; Link M; Krohn K; Peterson P; Uibo R
Int Immunol; 2008 Jan; 20(1):39-44. PubMed ID: 18000009
[TBL] [Abstract][Full Text] [Related]
11. Calcium-sensing receptor autoantibodies are relevant markers of acquired hypoparathyroidism.
Mayer A; Ploix C; Orgiazzi J; Desbos A; Moreira A; Vidal H; Monier JC; Bienvenu J; Fabien N
J Clin Endocrinol Metab; 2004 Sep; 89(9):4484-8. PubMed ID: 15356052
[TBL] [Abstract][Full Text] [Related]
12. Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1.
Meager A; Visvalingam K; Peterson P; Möll K; Murumägi A; Krohn K; Eskelin P; Perheentupa J; Husebye E; Kadota Y; Willcox N
PLoS Med; 2006 Jul; 3(7):e289. PubMed ID: 16784312
[TBL] [Abstract][Full Text] [Related]
13. TSGA10 - A target for autoantibodies in autoimmune polyendocrine syndrome type 1 and systemic lupus erythematosus.
Smith CJ; Oscarson M; Rönnblom L; Alimohammadi M; Perheentupa J; Husebye ES; Gustafsson J; Nordmark G; Meloni A; Crock PA; Kämpe O; Bensing S
Scand J Immunol; 2011 Feb; 73(2):147-53. PubMed ID: 21198756
[TBL] [Abstract][Full Text] [Related]
14. Autoantibody responses in autoimmune ovarian insufficiency and in Addison's disease are IgG1 dominated and suggest a predominant, but not exclusive, Th1 type of response.
Brozzetti A; Marzotti S; La Torre D; Bacosi ML; Morelli S; Bini V; Ambrosi B; Giordano R; Perniola R; De Bellis A; Betterle C; Falorni A;
Eur J Endocrinol; 2010 Aug; 163(2):309-17. PubMed ID: 20498138
[TBL] [Abstract][Full Text] [Related]
15. Pituitary autoantibodies in autoimmune polyendocrine syndrome type 1.
Bensing S; Fetissov SO; Mulder J; Perheentupa J; Gustafsson J; Husebye ES; Oscarson M; Ekwall O; Crock PA; Hökfelt T; Hulting AL; Kämpe O
Proc Natl Acad Sci U S A; 2007 Jan; 104(3):949-54. PubMed ID: 17215373
[TBL] [Abstract][Full Text] [Related]
16. [Hypoparathyroidism associated with autoimmune disorder].
Yamauchi M; Sugimoto T
Clin Calcium; 2007 Aug; 17(8):1193-9. PubMed ID: 17660615
[TBL] [Abstract][Full Text] [Related]
17. Calcium-sensing receptor autoantibodies in primary hyperparathyroidism.
Charrié A; Chikh K; Peix JL; Berger N; Decaussin M; Veber S; Bienvenu J; Lifante JC; Fabien N
Clin Chim Acta; 2009 Aug; 406(1-2):94-7. PubMed ID: 19520070
[TBL] [Abstract][Full Text] [Related]
18. Identification of endothelin-converting enzyme-2 as an autoantigen in autoimmune polyendocrine syndrome type 1.
Smith-Anttila CJA; Bensing S; Alimohammadi M; Dalin F; Oscarson M; Zhang MD; Perheentupa J; Husebye ES; Gustafsson J; Björklund P; Fransson A; Nordmark G; Rönnblom L; Meloni A; Scott RJ; Hökfelt T; Crock PA; Kämpe O
Autoimmunity; 2017 Jun; 50(4):223-231. PubMed ID: 28557628
[TBL] [Abstract][Full Text] [Related]
19. Cytochrome P450 1A2 is a hepatic autoantigen in autoimmune polyglandular syndrome type 1.
Clemente MG; Obermayer-Straub P; Meloni A; Strassburg CP; Arangino V; Tukey RH; De Virgiliis S; Manns MP
J Clin Endocrinol Metab; 1997 May; 82(5):1353-61. PubMed ID: 9141515
[TBL] [Abstract][Full Text] [Related]
20. Autoimmune polyendocrine syndrome type 1: an extensive longitudinal study in Sardinian patients.
Meloni A; Willcox N; Meager A; Atzeni M; Wolff AS; Husebye ES; Furcas M; Rosatelli MC; Cao A; Congia M
J Clin Endocrinol Metab; 2012 Apr; 97(4):1114-24. PubMed ID: 22344197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
